SBI Securities’s Pyxis Oncology PYXS Stock Holding History

SBI Securities’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53K	Buy	509 +508	+50,800%	+$971	﹤0.01%	2653
2026 Q1	$1	Hold	1	–	–	﹤0.01%	3991
2025 Q4	$1	Sell	1 -1	-50%	-$4	﹤0.01%	4003
2025 Q3	$4	Buy	2 +1	+100%	+$1	﹤0.01%	4121
2025 Q2	$1	Sell	1 -1	-50%	-$1	﹤0.01%	4128
2025 Q1	$2	Hold	2	–	–	﹤0.01%	4096
2024 Q4	$3	Buy	+2	New	+$6	﹤0.01%	4044

Other funds holding PYXS

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

HIMS

Hager Investment Management Services New London, New Hampshire $217M AUM 56.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FUBT

First United Bank & Trust Oakland, Maryland $348M AUM 25.01% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SBI Securities's PYXS Position: Q2 2026 in Review

SBI Securities increased its Pyxis Oncology (PYXS) stake by 50,800% in Q2 2026, buying an estimated $971 and bringing the position to 509 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

SBI Securities first reported a position in PYXS in Q4 2024 and has held it in 7 quarters since. 7 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

SBI Securities held 509 shares of Pyxis Oncology worth $1.53K as of Q2 2026.
SBI Securities bought 508 Pyxis Oncology shares in Q2 2026, an estimated $971.
Pyxis Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2653 holding.
SBI Securities first reported a position in Pyxis Oncology in Q4 2024 and has held it in 7 quarters since.
7 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.